You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

thalidomide

Showing 51 - 75 of 663
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Crohn Disease Trial in Italy (Thalidomide, Infliximab)

Terminated
  • Crohn Disease
  • Napoli, Campania, Italy
  • +5 more
Sep 2, 2020

Chronic Myeloproliferative Disorders, Leukemia, MDS Trial in Cleveland (ascorbic acid, arsenic trioxide, dexamethasone)

Completed
  • Chronic Myeloproliferative Disorders
  • +3 more
  • ascorbic acid
  • +3 more
  • Cleveland, Ohio
  • +1 more
Jul 23, 2020

Multiple Myeloma and Plasma Cell Tumor Trial in Canada (prednisone, thalidomide)

Completed
Has Results
  • Multiple Myeloma and Plasma Cell Neoplasm
  • Calgary, Alberta, Canada
  • +17 more
Sep 11, 2020

Multicentric Castleman Disease Trial in Beijing (Thalidomide, cyclophosphamide and prednisone)

Unknown status
Has Results
  • Multicentric Castleman Disease
  • Thalidomide, cyclophosphamide and prednisone
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Apr 5, 2020

T-LGL Leukemia, Clpd-Nk Trial in China (thalidomide + prednisone + methotrexate)

Recruiting
  • T-LGL Leukemia
  • Clpd-Nk
  • thalidomide + prednisone + methotrexate
  • Nanning, Guangxi, China
  • +8 more
Jun 26, 2020

COVID-19 Thalidomide Trial (, Thalidomide)

Unknown status
  • COVID-19 Thalidomide
  • placebo
  • Thalidomide
  • (no location specified)
Feb 19, 2020

COVID-19 Thalidomide Trial (thalidomide, )

Unknown status
  • COVID-19 Thalidomide
  • thalidomide
  • placebo
  • (no location specified)
Feb 19, 2020

Plasma Cell Myeloma Trial in Israel, United States (Laboratory Biomarker Analysis, Lenalidomide, Melphalan)

Active, not recruiting
Has Results
  • Plasma Cell Myeloma
  • Laboratory Biomarker Analysis
  • +5 more
  • Mobile, Alabama
  • +392 more
Jan 25, 2023

Diffuse Large B-cell Lymphoma Trial in ZhengZhou (Chidamide, Vinorelbine, Liposomal Doxorubicin or mitoxantrone)

Unknown status
  • Diffuse Large B-cell Lymphoma
  • ZhengZhou, Henan, China
    Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
Mar 31, 2020

Multiple Myeloma Trial in Singapore (Bortezomib, Cyclophosphamide, Dexamethasone)

Unknown status
  • Multiple Myeloma
  • Singapore, Singapore
    National University Hospital
Jan 23, 2020

Radiation Injuries Trial in Guangzhou, Guanzhou (Thalidomide)

Unknown status
  • Radiation Injuries
  • Thalidomide
  • Guangzhou, Guangdong, China
  • +2 more
Nov 21, 2019

Multiple Myeloma Trial in Brazil (Ixazomib, Thalidomide, Dexamethasone)

Withdrawn
  • Multiple Myeloma
  • Salvador, BA, Brazil
  • +5 more
Jan 10, 2020

Multiple Myeloma Trial in France, United Kingdom (Thalidomide Celgene™)

Completed
  • Multiple Myeloma
  • Thalidomide Celgene™
  • Brest Cedex, France
  • +6 more
Nov 7, 2019

Multiple Myeloma and Plasma Cell Tumor Trial in Baltimore, New York (oblimersen sodium, dexamethasone, thalidomide)

Completed
  • Multiple Myeloma and Plasma Cell Neoplasm
  • oblimersen sodium
  • +2 more
  • Baltimore, Maryland
  • +1 more
Oct 15, 2019

Multiple Myeloma Trial in Belgium, France, Netherlands (Bortezomib (VELCADE), Thalidomide, and Dexamethasone (VTD), Bortezomib,

Active, not recruiting
  • Multiple Myeloma
  • Bortezomib (VELCADE), Thalidomide, and Dexamethasone (VTD)
  • +2 more
  • Antwerp, Belgium
  • +106 more
Dec 3, 2020

Erythema Nodosum Leprosum Trial in Worldwide (Methotrexate, Placebo, Prednisolone)

Not yet recruiting
  • Erythema Nodosum Leprosum
  • Dhaka, Bangladesh
  • +6 more
Aug 23, 2022

Stem Cells Mobilization, colLection and Engraftment in Newly

Recruiting
  • Multiple Myeloma
  • +3 more
  • Rome, Italy
    Fondazione Policlinico Universitario A.Gemelli IRCCS
Apr 28, 2023

Recurrent Uterine Corpus Sarcoma, Uterine Carcinosarcoma Trial in Philadelphia (Laboratory Biomarker Analysis, Thalidomide)

Completed
Has Results
  • Recurrent Uterine Corpus Sarcoma
  • Uterine Carcinosarcoma
  • Laboratory Biomarker Analysis
  • Thalidomide
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Jul 22, 2019

Recurrent Uterine Corpus Sarcoma, Uterine Corpus Leiomyosarcoma Trial in Philadelphia (Thalidomide, Laboratory Biomarker

Completed
  • Recurrent Uterine Corpus Sarcoma
  • Uterine Corpus Leiomyosarcoma
  • Thalidomide
  • Laboratory Biomarker Analysis
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Jul 22, 2019

Gastrointestinal Vascular Malformation Trial in China (Thalidomide (100mg), Thalidomide (50mg), )

Unknown status
  • Gastrointestinal Vascular Malformation
  • Thalidomide (100mg)
  • +2 more
  • Beijing, Beijing, China
  • +10 more
Sep 19, 2019

Fallopian Tube Cancer, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer Trial in Philadelphia (tamoxifen

Completed
Has Results
  • Fallopian Tube Cancer
  • +4 more
  • tamoxifen citrate
  • +2 more
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Jul 22, 2019

Multiple Myeloma Trial in Austria, Czechia, Germany (Ixazomib, Thalidomide, Dexamethasone)

Completed
  • Multiple Myeloma
  • Linz, Oberösterreich, Austria
  • +16 more
Dec 12, 2019

Advanced HCC Trial (Lenalidomide)

Not yet recruiting
  • Advanced HCC
  • (no location specified)
Apr 16, 2023

Maintenance With Bortezomib Plus Daratumumab After Induction

Recruiting
  • Multiple Myeloma
  • Non-eligible for Autologous Stem Cell Transplantation (ASCT)
  • Arganda Del Rey, Spain
  • +31 more
Sep 15, 2022

Advanced Nsclc Trial in Jinan (Thalidomide, pemetrexed, cisplatin)

Unknown status
  • Advanced Nsclc
  • Thalidomide
  • +3 more
  • Jinan, Shandong, China
    Qilu hospital of Shandong University
Jun 3, 2019